RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Research & development

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.5B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202469+1.02%
Dec 31, 202368+16.92%
Dec 31, 202259+10.80%
Dec 31, 202153+12.58%
Dec 31, 202047+20.57%
Dec 31, 201939-3.47%
Dec 31, 201840+3.07%
Dec 31, 201739+6.25%
Dec 31, 201637+7.92%
Dec 31, 201534-8.58%
Dec 31, 201437-1.58%
Dec 31, 201338+14.16%
Dec 31, 201233+38.91%
Dec 31, 201024

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)